Kedudukan dalam Saham
#29054
PT Indofarma Tbk, along with its affiliated entities, is dedicated to the... PT Indofarma Tbk, along with its affiliated entities, is dedicated to the production and marketing of pharmaceutical goods across Indonesia. The company's activities encompass the commerce and supply of a diverse range of items, including medications, medical equipment, healthcare provisions, various extracts, and herbal products. It also operates its own laboratory facilities and provides specific COVID-19 diagnostic services, such as rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), and Genose tests. Additionally, the firm engages in the export of its merchandise. Established in 1918, Indofarma Tbk maintains its primary operations in Bekasi, Indonesia. Historically, the company was known as PT Indofarma (Persero) Tbk and now functions as a subsidiary of PT. Bio Farma.
Harga Saham
$0.00748841
Disegerakkan terakhir: 2024-07-01
Perubahan (1 hari)
-2.83%
Perubahan (1 tahun)
0.00%
Perdagangan PT Indofarma Tbk (INAF)
Harga INAF dengan permodalan pasaran b
Modal pasaran bagi PT Indofarma Tbk(INAF)
Modal Pasaran: $23.21M
Sehingga August 2026, PT Indofarma Tbk mempunyai modal pasaran sebanyak $23.21M. Ini menjadikan PT Indofarma Tbk syarikat ke-29054th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran PT Indofarma Tbk dari 2001 hingga 2026
INAF berbanding dengan 5 teratas yang paling popular stocks
| Harga INAF |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.310T
|
+22,879,229.90%
|
|
|
|
|
$4.627T
|
+19,935,985.56%
|
|
|
|
|
$4.144T
|
+17,855,036.24%
|
|
|
|
|
$3.599T
|
+15,505,368.38%
|
|
|
|
|
$2.842T
|
+12,244,550.60%
|
